首页 /科研细胞 /科研细胞 /科研细胞 /BT-20(人乳腺癌细胞)

BT-20(人乳腺癌细胞)

CBP60354

询 价
索取STR
产品描述
产品数据库
I. General information
Synonyms: BT-20
Background: This breast tumor line was established by E.Y. Lasfargues and L. Ozzello in 1958 by isolation and cultivation of cells spilling out of the tumor when it was cut in thin slices. ­
Species: Homo sapiens, human
Tissue: mammary gland/breast
Disease: carcinoma
Gender: female, 74 years, Caucasian
Morphology: epithelial
Growth Mode: adherent
DNA Profile: Amelogenin: X
CSF1PO: 12
D13S317: 11
D16S539: 11,14
D5S818: 12
D7S820: 10
THO1: 7,9.3
TPOX: 11
vWA: 16,17
Cobioer’s Cell Line Authentication Service
Culture Medium:

MEM + 10% FBS+ 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP)+10ug/ml insulin or 1% ITS-G(GIBCO 41400045)

BT-20完全培养基,# CBP60354M
We strongly suggest to purchase the complete medium from Cobioer.

Cryopreservation medium: 90%FBS+10%DMSO
Antigen Expression: Antigen expression: HLA A1, Bw16 (+/-)
Tumor Formation: Yes, in nude mice
(The cells form grade II adenocarcinomas.)
Comments: The cells express the WNT3 and the WNT7B oncogenes [PubMed: 8168088].
A mycoplasma contaminant was discovered and eliminated early in 1972.
Growth of BT-20 cells is inhibited by tumor necrosis factor alpha (TNF alpha).
BT-20 cells are negative for estrogen receptor, but do express an estrogen receptor mRNA that has deletion of exon 5.
For more information, please contact Cobioer (4008-750-250).

药靶模型联系方式: 华东销售经理:18240630236 全国销售经理:18066071954
诊断标准品联系方式: 华东销售经理:15000320447 华北销售经理:18131625521 华南销售经理:13484295986 华中&西南销售经理:13871580511 全国销售经理:13484295986

扫二维码

立即提交